Upper Endoscopy Finding

Normal

Gastritis

GU

DU

Reflux esophagitis

Malignancy

Total

p-value

Case numbers (prevalence)

1174 (56.9%)

215 (10.4%)

254 (12.3%)

194 (9.4%)

182 (8.8%)

43 (2.1%)

2062 (100%)

Age (years)

47.36 ± 15.43

55.42 ± 14.69

60.44 ± 15.27

51.99 ± 16.24

51.87 ± 17.99

61.12 ± 14.32

0.001a

Gender

Male

473 (40.3%)

106 (49.3%)

142 (55.8%)

110 (56.7%)

116 (63.7%)

30 (69.8%)

977 (47.4%)

0.001b

Female

701 (59.7%)

109 (50.7%)

112 (44.1%)

84 (43.3%)

66 (36.3%)

13 (30.2%)

1085 (52.6%)

H.P.

Positive

141 (12.0%)

75 (51.1%)

144 (56.7%)

111 (57.2%)

8 (4.4%)

7 (16.2%)

438 (21.2%)

0.001b

Negative

632 (53.8%)

110 (34.9%)

96 (37.8%)

73 (37.6%)

111 (61%)

30 (69.8%)

1100 (53.3%)

Not done

401 (34.2%)

30 (14%)

14 (5.5%)

10 (5.2%)

63 (34.6%)

6 (14%)

524 (25.4%)

Combined medication

Nil

1143 (97.4%)

197 (91.6%)

218 (85.8%)

187 (96.4%)

177 (97.3%)

42 (97.7%)

1964 (25.4%)

Aspirin

19 (1.6%)

18 (8.4%)

19 (7.5%)

3 (1.5%)

4 (2.2%)

1 (2.3%)

64 (3.1%)

0.001b

NSAIDs

9 (0.8%)

0

15(5.9%)

4 (2.1%)

1 (0.5%)

0

29 (1.4%)

0.001b

Coumadin

3 (0.3%)

0

2 (0.8%)

0

0

0

5 (2%)

0.384b

Risk factors

Nil

1105 (94.1%)

193 (89.8%)

218 (85.8%)

163 (84%)

173 (95.2%)

17 (39.5%)

1869 (90.6%)

GI bleeds

23 (2%)

10 (4.6%)

21 (8.3%)

22 (11.3%)

3 (1.6%)

9 (20.9%)

88 (4.3%)

0.001b

BWL

25 (2.1%)

6 (2.8%)

9 (3.5%)

4 (2.1%)

3 (1.6%)

11 (25.6%)

58 (2.8%)

0.001b

Poor drug response

20 (1.7%)

6 (2.8%)

6 (2.4%)

5 (2.6%)

3 (1.6%)

1 (2.3%)

41 (2%)

0.630b

Dysphagia

1 (0.1%)

0

0

0

0

5 (11.6%)

6 (3%)

0.001b